Profil
Stanley Hirsch's career history includes current and former positions as well as his education background.
Currently, he serves as the Group Chief Executive Officer & Director at FuturaGene Ltd., the Chief Executive Officer at FuturaGene, Inc., and the Director at Matricelf Ltd. In the past, he held positions such as Chief Executive Officer at CBD Technologies, Inc., Chairman at VYNE Pharmaceuticals Ltd. from 2016 to 2020, Chairman at OWC Pharmaceutical Research Corp.
from 2017 to 2020, Chairman at One World Cannabis Ltd., Director at Menlo Therapeutics, Inc. in 2020, and General Manager at Portman Pharmaceuticals, Inc. Dr. Hirsch obtained a doctorate degree from the University of Oxford in 1982 and an undergraduate degree from the University of Cape Town in 1979.
Postes actifs de Stanley Hirsch
| Sociétés | Poste | Début |
|---|---|---|
| MATRICELF LTD | Directeur/Membre du Conseil | 27/07/2022 |
FuturaGene Ltd.
FuturaGene Ltd. BiotechnologyHealth Technology Researches and develops plant genetic for global biofuel, forestry and agricultural markets | Directeur Général | 15/08/2007 |
FuturaGene, Inc.
FuturaGene, Inc. Other Metals/MineralsNon-Energy Minerals Develops chemical products for plants | Directeur Général | - |
Anciens postes connus de Stanley Hirsch
| Sociétés | Poste | Fin |
|---|---|---|
| VYNE THERAPEUTICS INC. | Directeur/Membre du Conseil | 09/04/2020 |
| OWC PHARMACEUTICAL RESEARCH CORP. | Président | 12/03/2020 |
One World Cannabis Ltd.
One World Cannabis Ltd. Pharmaceuticals: MajorHealth Technology Develops cannabis based medical products | Président | 12/03/2020 |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Président | 09/03/2020 |
Portman Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Formation de Stanley Hirsch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Health Technology |
OWC Pharmaceutical Research Corp.
OWC Pharmaceutical Research Corp. MiscellaneousMiscellaneous Develops and markets medical instruments and electromagnetic percussion devices | Miscellaneous |
Menlo Therapeutics, Inc.
Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
FuturaGene Ltd.
FuturaGene Ltd. BiotechnologyHealth Technology Researches and develops plant genetic for global biofuel, forestry and agricultural markets | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FuturaGene, Inc.
FuturaGene, Inc. Other Metals/MineralsNon-Energy Minerals Develops chemical products for plants | Non-Energy Minerals |
University of Cape Town
University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CBD Technologies, Inc.
CBD Technologies, Inc. TextilesProcess Industries Provides biotechnology for forest improvement and the development of biologically-based, clean processes for paper manufacturing | Process Industries |
Portman Pharmaceuticals, Inc. | |
One World Cannabis Ltd.
One World Cannabis Ltd. Pharmaceuticals: MajorHealth Technology Develops cannabis based medical products | Health Technology |
Matricelf Ltd.
Matricelf Ltd. BiotechnologyHealth Technology Develops platform for autologous matrix and cells implants for a wide range of medical conditions | Health Technology |
















